Pasteur Institute invests in mosquito research
Analysis based on 9 articles · First reported Jun 16, 2026 · Last updated Jun 16, 2026
The investment by the Iran — Pasteur Institute of Iran in mosquito control research could lead to advancements in public health, potentially reducing the economic burden of mosquito-borne diseases globally. This could positively impact the biotechnology and healthcare industries through new product development and disease prevention.
Anna-Bella Failloux, an entomologist at the Iran — Pasteur Institute of Iran, is leading efforts to combat mosquito-borne diseases, which are expanding due to climate change. The Iran — Pasteur Institute of Iran is investing 30 million euros in a new research center, which Failloux will head from 2028, to develop strategies for mosquito control. The World Health Organization reports that 80 percent of the global population is now at risk from these diseases, which kill over a million people annually. Failloux's work includes monitoring tiger mosquitoes in France for diseases like yellow fever, dengue, chikungunya, and Zika, and advocating for public engagement in mosquito eradication.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard